Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... Aim. To study the effect of replacing clopidogrel with ticagrelor on endpoints of hospital period ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... .5%) patients received clopidogrel, 17 (16.5%) – ticagrelor. After therapy correction based on genotype GA ..."
 
Vol 8, No 4 (2012) ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin
"... agents is discussed, especially this for ticagrelor which is the first-line drug in acute coronary ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... agents all over the world is clopidogrel, R2Y12-receptor blocker. It is shown that clopidogrel has ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... of clopidogrel, the association of residual platelet reactivity with clinical outcomes and a review ..."
 
Vol 13, No 4 (2017) PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW Abstract  similar documents
I. S. Yavelov
"... , ticagrelor, in patients with high risk of thrombotic complications of atherosclerosis with a history ..."
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... with clopidogrel or ticagrelor was performed, as well as of all 3 P2Y12-receptor inhibitors among themselves ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, inhibitors ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... of the formation of the active clopidogrel metabolite, for efficacy and safety of this drug in cardiology practice ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor inhibitors ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... Aim. To study therapeutic equivalence (efficacy, safety and tolerability) of original clopidogrel ..."
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"... производите- ля, замене тикагрелора или просугрела на клопидогрел для оценки эффекта отмены препарата. В ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance ..."
 
Vol 6, No 4 (2010) ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? Abstract  similar documents
S. J. Martsevich
"... The ACC/AHA clopidogrel clinical alert about the possibility of ineffective treatment ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... The possibilities and evidence base of clopidogrel use in clinical practice are discussed. Data ..."
 
Vol 10, No 6 (2014) СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? Abstract  similar documents
S. Yu. Martsevich, A. Yu. Suvorov
"... Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... years. It was assumed that the patients were receiving either generic clopidogrel or ticagrelor for 1 ..."
 
Vol 14, No 2 (2018) WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
M. Yu. Gilyarov, Е. V. Konstantinova
"... of reperfusion and the selected treatment strategy. Due to some limitations in the use of clopidogrel ..."
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... Aim. To analyze the literary and own data about clopidogrel influence on platelets during ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... of clopidogrel’s active metabolite and, respectively, its antiplatelet effect. We sought to determine the impact ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogrel ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... . Ключевые слова: антитромбоцитарные препараты, клопидогрель, резистентность к ацетилсалициловой кислоте. РФК ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic acid, emclopidogrel/em ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... is emclopidogrel/em. It has been proven that the use of emclopidogrel/em to date not always reduces the risk of development ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... effect of emclopidogrel/em, thus changing efficacy and safety of its standard dose. Aim. To study the impact ..."
 
Vol 14, No 5 (2018) Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case Abstract  similar documents
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov
"...   for resistance to antiplatelet therapy with emclopidogrel/em. The decrease in the effectiveness of prolonged therapy ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... .8% of patients also received combination of emclopidogrel/em and acetylsalicylic acid, but changed medicinal products ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... Введение. Полученные ранее данные свидетельствуют о наличии у emклопидогрела/em не только ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... and induced flow cytofluorometry during antiplatelet therapy with emclopidogrel/em and acetylsalicylic acid (ASA ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , warfarin, ticlopidine and emclopidogrel/em are discussed. Study data on new antiplatelet drugs are given ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... ), encoding P-glycoprotein, in pharmacotherapy with digoxin, antiplatelet drugs (emclopidogrel/em tikagrelol ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and emclopidogrel/em resistance ..."
 
Vol 8, No 2 (2012): РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ ОСТРОГО КОРОНАРНОГО СИНДРОМА БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST Abstract  similar documents
, , , , , , , , , , , , , , , ,
"... , бивалирудин, шунтирование, отделение неотложной кардиологии, emклопидогрел/em, диабет, эноксапарин, Европейское ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and emclopidogrel/em and clinical ..."
 
Vol 5, No 1 (2009) PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich
"... ПРОБЛЕМА ДЖЕНЕРИЧЕСКОЙ emЗАМЕНЫ/em: ПЛЮСЫ И МИНУСЫ С.Н. Толпыгина*, С.Ю. Марцевич Государственный ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... , emзамене/em emклопидогрела/em од- ного производителя на emклопидогрел/em другого про- изводителя, emзамене/em emтикагрелора/em или ..."
 
Vol 12, No 1 (2016) Acute coronary syndrome and renal dysfunction Abstract  similar documents
F. I. Belyalov
"... . et al. emTicagrelor/em Versus emClopidogrel/em in Acute Coronary Syndromes in Re- lation to Renal Function ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... фозиноприла у больных артериальной гипертонией (АГ) 1-2 степени и оценка экономической эффективности emзамены/em ..."
 
Vol 8, No 2 (2012): КОММЕНТАРИИ К НОВОМУ ВАРИАНТУ ЕВРОПЕЙСКИХ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ТАКТИКЕ ЛЕЧЕНИЯ БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST Abstract  similar documents
"... отсутствие, прием антиагреган- та emтикагрелора/em по сравнению с emклопидогрелом/em приво- дил к статистически ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... Heart J 2009;30:1753-63. 55. Wallentin L., Becker R.C., Budaj A., et al. emTicagrelor/em versus emclopidogrel/em ..."
 
Vol 7, No 6 (2011) PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES Abstract  similar documents
R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova
"... , and emclopidogrel/em was not prescribed. At the same hospital clotting time was determined for monitoring of heparin ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... of revealed disorders with antiplatelet agent — emclopidogrel/em 75 mg/day. Material and methods. 40 patients ..."
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... antiplatelet therapy with acetyl salicylic acid and emclopidogrel/em. Numerous clinical characteristics ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... antiplatelet drugs (acetylsalicylic acid and emclopidogrel/em) and heparin. There were not any reasons ..."
 
Vol 7, No 3 (2011) THE NEWS FROM RECENT CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY (NEW ORLEANS, APRIL 2-5, 2011)  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Y. Drozdova
"... emклопидогрел/em. Большинство склонялось к мнению, что на сегодняшний день есть все основа- ния считать emтикагрелор/em ..."
 
Vol 10, No 6 (2014) PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING Abstract  similar documents
N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov
"... . emКлопидогрел/em, CYP2C19 Кровотечение или уменьшение Рассмотреть возможность назначения emТикагрелор/em, эффективности ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... + emclopidogrel/em) can be prescribed to elderly patients with cardiovascular comorbidity who are deemed unsuitable ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... therapy (acetylsalicylic acid, emclopidogrel/em, warfarin) was made on the 4th day of disease onset taking ..."
 
Vol 4, No 3 (2008) ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Abstract  similar documents
V. A. Sulimov
"... сравнительной эффективности и без- опасности emтикагрелора/em и emклопидогреля/em будет получе- на после завершения ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... . emЗамена/em АСК на emклопидогрел/em не считается опти- мальной стратегией профилактики кровотечений у пациентов с ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... with ASA and emclopidogrel/em, risk of thrombotic events is saved in ASA resistant patients with ACS ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... . 51.8% of respondents recommend a combination of acetylsalicylic acid and emclopidogrel/em ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... in trials and proven efficacy in the prevention of stroke/systemic embolism, the use of emclopidogrel/em ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... pharmacies. Among antiplatelet agents, aspirin was available in most pharmacies, and emclopidogrel/em was mostly ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... (3.8%) patients. Aspirin was the only antiplatelet agent in 3 cases and emclopidogrel/em – in one case ..."
 
Vol 10, No 2 (2014) RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Abstract  similar documents
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson
"... . Lancet 2009;373:723-31. 7. Steg P.G., James S., Harrington R.A., et al. emTicagrelor/em versus emclopidogrel/em ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... by half in patients aged ≥75 years) in combination with emclopidogrel/em and enoxaparin followed by admission ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... receptors (AMCR), diuretics, oral anticoagulants, emclopidogrel/em increased (p0.05). In the structure ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... with emclopidogrel/em (up to 5.4%) was registered at the second stage of the study. Over a five-year period bisoprolol ..."
 
Vol 13, No 3 (2017) ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION Abstract  similar documents
F. I. Belyalov
"... - тромбоцитарный эффект emклопидогрела/em и, соответ- ственно, повышается риск неблагоприятных событий после коронарного ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... нагрузочной дозой АСК. Поскольку emклопидогрел/em и emтикагрелор/em мед- ленно достигают своего максимального ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... : antiplatelet agents – in 60.4% of the cases (584 patients received acetylsalicylic acid and 20 – emclopidogrel/em ..."
 
Vol 5, No 5 (2009) ANTIAGGREGANT THERAPY OVERCOMES LIMITS Abstract  similar documents
I. Andreeva
"... На отечественном фармацевтическом рынке по- явился новый европейский emклопидогрел/em — Эгитромб (Эгис ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... +emclopidogrel/em (75 mg/day). The aggregation study was performed with an optical aggregometer, using 5 μM ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... emклопидогрелом/em или emтикагрелором/em приводит к сопоста- вимой частоте клинически значимых кровотечений по сравнению с ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CONTROL RANDOMIZED STUDIES IN 2009: WHAT IS NEW IN CARDIOLOGY Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... emклопидогрел/em) при ОКС имеет преимущества перед терапией только АСК (исследования CURE, COMMIT), однако эта же ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... - тернативой АСК. Существовавшие до недавнего вре- мени рекомендации по emзамене/em АСК на emклопидогрель/em у больных ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... - тельного риска смерти с 12 до 25% [7]. Пациенты, самостоятельно прекратившие принимать emклопидогрел/em в ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... (emклопидогрел/em, прасугрел, emтикагрелор/em, блокаторы гликопротеиновых рецепторов IIb/IIIa), ин- гибиторы Ха-фактора ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... по своей эффективности (на 40%) соче- тание emклопидогрела/em и АСК по данным исследования ACTIVE-W [7 ..."
 
Vol 6, No 5 (2010) THE CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY 2010 IN STOCKHOLM: NEWS FOR PRACTITIONERS Abstract  similar documents
S. Yu. Martsevich
"... назначение двух антиагрегантов — аспирина и emклопидогрела/em (так называемая двойная ан- тиагрегантная терапия ..."
 
Vol 6, No 1 (2010) CARDIOLOGY: REALITY AND PROSPECTIVE. RESULTS OF RUSSIAN NATIONAL CONGRESS OF CARDIOLOGY Abstract  similar documents
O. V. Gaysenok, A. S. Lishuta
"... с emклопидогрелом/em имел меньше случаев тромбоза стента. В исследовании Сurrent Oasis 7 (emClopidogrel/em ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... ). Пациентам проводили emзамену/em β-блокатора на карведилол. Исходно, во время приема карведилола и после его ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... Дипиридамол emClopidogrel/em emКлопидогрел/em Ticlopidine Тиклопидин Antiplatelet agents (without names ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... циклооксигеназы Ацетилсалициловая кислота Блокаторы фосфолипазы C Тиклопидин Блокаторы АДФ-рецепторов emКлопидогрел/em ..."
 
Vol 8, No 6 (2012) SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... , включившее 19185 пациентов выявило, что emклопидогрел/em оказался значимо лучше в предотвращении нефатального ОИМ ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... группы: АСК+дипиридамол за- медленного высвобождения и emклопидогрел/em (средняя продолжительность наблюдения ..."
 
Vol 11, No 5 (2015) Subscription to the journal Abstract  similar documents
article Editorial
"... ) ISSN 1819-6446 (Print) ISSN 2225-3653 (Online) CYP3A4 and CYP2C19: emclopidogrel/em antiplatelet effect in ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... контроля составили 184 человека. Генотипирование по однонуклеотидным emзаменам/em Glu298Asp гена эндотелиальной ..."
 
Vol 14, No 1 (2018) STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) Abstract  similar documents
S. V. Povetkin, Ju. V. Luneva
"... группах проводили emзамену/em препарата на сравниваемый в эквивалентных дозах, и наблюдали пациентов еще в ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... , одновременное назначение кортикосте- роидов, клинические признаки диспепсии) [37,39]. emЗамена/em АСК на emклопидогрел/em ..."
 
Vol 2, No 3 (2006) CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES Abstract  similar documents
P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian
"... . Фосфолипиды мембран Аспирин Агрегация тромбоцитов Тиклопидин/ emКлопидогрель/em Активация агрегации ..."
 
Vol 14, No 1 (2018) COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH Abstract  similar documents
I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii
"... обоснование emзамены/em ингибиторов протонной помпы с учетом вероятности межлекарственных взаимодействий у пациента ..."
 
Vol 14, No 4 (2018) Statin Therapy and Cognitive Impairment: Benefit or Harm? Abstract  similar documents
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova
"... случае прекращения приема статина следует подумать об альтернативной emзамене/em на другой ингибитор ГМК ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... ацетилсалициловая кислота (АСК) и emклопидогрел/em [4]. АСК, emклопидогрел/em или их сочетание («двойная ан- титромбоцитарная ..."
 
Vol 7, No 5 (2011) EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY Abstract  similar documents
R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek
"... пациентов в случайном порядке назначали ивабрадин на 14 дн с emзаменой/em его на бисопролол сроком на 3 мес ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... , 20%) than those with combination of AF and IHD (19 of 515; 3.7%), p=0.002. Aspirin and emclopidogrel/em ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
"... ингибитор тромбоцитов (emклопидогрел/em). В исследова- ние были включены здоровые некурящие доброволь- цы в ..."
 
Vol 3, No 1 (2007) COMMENTS ON EUROPEAN GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (2006) Abstract  similar documents
S. Y. Martsevich
"... уже ниже (IIa). То же гово- рится о назначение emклопидогреля/em вместо аспирина (это рекомендуется лишь в ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... emклопидогрела/em. В ис- следовании ACTIVE оценивались эффективность и безопасность сочетания аспирина и ..."
 
Vol 7, No 5 (2011): ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОЙ ТЕРАПИИ ПРИ ПЕРВИЧНОЙ И ВТОРИЧНОЙ ПРОФИЛАКТИКЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. РЕКОМЕНДАЦИИ ВНОК, 2011 Abstract  similar documents
, , , , , , , ,
"... Investigating Outcome with Nifedipine GITS ACTIVE - Atrial Fibrillation emClopidogrel/em Trial with Irbesartan for ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... treatment of IHD / Динамика лекарственной терапии при ИБС acetylsalicylic acid (ASA) and emclopidogrel/em (level ..."
 
Vol 12, No 6 (2016) THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION Abstract  similar documents
T. E. Imaev, A. E. Komlev, R. S. Akchurin
"... , обоснованным альтернативным подходом хирургической emзамене/em клапана у больных высокого хирургического риска, что ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... недостаточности, а также антигипертензивные препараты. Проблема emзамены/em лекарств Следует учитывать, что данные о ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... - тилсалициловую кислоту (АСК) [2] и комбинированную терапию АСК и emклопидогрелом/em [3]. Недостатки варфарина ..."
 
1 - 100 of 266 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)